19
Jun
2024

HEBEI VEYONG PHARMACEUTICAL CO., LTD.

Exhibitor at CPHI & PMEC China 2024 stand E2A20, Pharma Ingredients
About Us

We are the largest producer of Avermectin in the globe and the largest producer of Ivermectin in Asia , with annual output shares half of the total in China. We are also the largest manufacturer for Tiamulin, Eprinomectin and Emamectin Benzoate in China.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Contact info
  • Website
  • No.68 Ganjiang Road, Shijiazhuang, Hebei, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand E2A20, Pharma Ingredients

Products Featured at CPHI & PMEC China 2024

  • 10%Oxytetracycline +1%Lidocaine

    Product 10%Oxytetracycline +1%Lidocaine

    Hebei veyong animal pharmaceutical co. offers a wide range of products which includes 10%Oxytetracycline +1%Lidocaine. It belongs to liquid injection category. It can be produced with 10ml ampoule and 5?30ml, 50ml, 100ml bottles. Diversified specification and package are available on the basis of clients n...
  • 4% TMP+40% Sulfadiazine

    Product 4% TMP+40% Sulfadiazine

    Hebei veyong animal pharmaceutical co. offers a wide range of products which includes 4% TMP+40% Sulfadiazine. It belongs to solution for oral category. Content: 100ml, 250ml.500ml, 1000ml. Diversified specification and package are available on the basis of clients needs. Contact us for more information.
  • 5%Oxytetracycline +1%Lidocaine

    Product 5%Oxytetracycline +1%Lidocaine

    Hebei veyong animal pharmaceutical co. offers a wide range of products which includes 5%Oxytetracycline +1%Lidocaine. It belongs to liquid injection category. It can be produced with 10ml ampoule and 5?30ml, 50ml, 100ml bottles. Diversified specification and package are available on the basis of clients ne...